Preparation, characterization, and in vitro release studies of insulin-loaded double-walled poly(lactide-co-glycolide) microspheres

Drug Deliv Transl Res. 2016 Jun;6(3):308-18. doi: 10.1007/s13346-016-0278-y.

Abstract

The purpose of this study was to fabricate insulin-loaded double-walled and single-polymer poly(lactide-co-glycolide) (PLGA) microspheres using a fast degrading glucose core, hydroxyl-terminated poly(lactide-co-glycolide) (Glu-PLGA), and a moderate degrading carboxyl-terminated PLGA polymers. A modified water-in-oil-in-oil-in-water (w/o/o/w) emulsion solvent evaporation technique was employed to prepare double-walled microspheres, whereas single-polymer microspheres were fabricated by a conventional water-in-oil-in-water (w/o/w) emulsion solvent evaporation method. The effect of fabrication techniques and polymer characteristics on microspheres size, morphology, encapsulation efficiency, in vitro release, and insulin stability was evaluated. The prepared double-walled microspheres were essentially non-porous, smooth surfaced, and spherical in shape, whereas single-polymer microspheres were highly porous. Double-walled microspheres exhibited a significantly reduced initial burst followed by sustained and almost complete release of insulin compared to single-polymer microspheres. Initial burst release was further suppressed from double-walled microspheres when the mass ratio of the component polymers was increased. In conclusion, double-walled microspheres made of Glu-PLGA and PLGA can be a potential delivery system of therapeutic insulin.

Keywords: Burst release; Double-walled microspheres; Encapsulation efficiency; Poly(lactide-co-glycolide); Sustained release.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drug Delivery Systems / methods
  • Drug Liberation
  • Drug Stability
  • Emulsions
  • Glucose / chemistry
  • Insulin / chemistry
  • Insulin / pharmacokinetics*
  • Microscopy, Electron, Scanning
  • Microspheres*
  • Particle Size
  • Polyglactin 910 / chemistry*
  • Technology, Pharmaceutical / methods

Substances

  • Emulsions
  • Insulin
  • Polyglactin 910
  • Glucose